Clinical performance of different SARS‐CoV‐2 IgG antibody tests
Open Access
- 8 June 2020
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (10), 2243-2247
- https://doi.org/10.1002/jmv.26145
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) serological assays are urgently needed for rapid diagnosis, contact tracing, and for epidemiological studies. So far, there is limited data on how commercially available tests perform with real patient samples, and if positive tested samples show neutralizing abilities. Focusing on IgG antibodies, we demonstrate the performance of two enzyme‐linked immunosorbent assay (ELISA) assays (Euroimmun SARS‐CoV‐2 IgG and Vircell COVID‐19 ELISA IgG) in comparison to one lateral flow assay (FaStep COVID‐19 IgG/IgM Rapid Test Device) and two in‐house developed assays (immunofluorescence assay [IFA] and plaque reduction neutralization test [PRNT]). We tested follow up serum/plasma samples of individuals polymerase chain reaction‐diagnosed with COVID‐19. Most of the SARS‐CoV‐2 samples were from individuals with moderate to the severe clinical course, who required an in‐patient hospital stay. For all examined assays, the sensitivity ranged from 58.8 to 76.5% for the early phase of infection (days 5‐9) and from 93.8% to 100% for the later period (days 10‐18).Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS‐CoV‐2)Journal of Medical Virology, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease PatientsEmerging Infectious Diseases, 2020
- Aberrant Gray Matter Volume and Cortical Surface in Paranoid-Type Delusional DisorderNeuropsychobiology, 2020
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2Journal of Clinical Microbiology, 2020
- Epstein‐Barr virus related post‐transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantationReviews in Medical Virology, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room departmentJournal of Medical Virology, 2020
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoVNature Communications, 2020
- SARS-CoV-2 and Coronavirus Disease 2019: What We Know So FarPathogens, 2020
- Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2International Journal of Biological Sciences, 2020